The Company has a 52-to-53-week fiscal year that ends on the last Saturday in June. Accordingly, every fifth or sixth fiscal year will be a 53-week fiscal year. Fiscal year 2018 was a 53-week fiscal year and fiscal year 2019 is a 52-week fiscal year. The second quarter of fiscal year 2018 was a 14-week quarter and the second quarter of fiscal year 2019 was a 13-week quarter.
In the three and nine months ended March 30, 2019, the Company recorded an income tax provision of $29.8 million and $116.8 million, respectively, compared to $28.7 million and $328.0 million for the three and nine months ended March 31, 2018, respectively. The Company’s effective tax rate for the three and nine months ended March 30, 2019 was 18.6% and 20.3%, respectively, compared to the 12.9% and 54.6% for the three and nine months ended March 31, 2018, respectively. 
The expenses included in the Condensed Consolidated Statements of Income for RSUs include expenses related to MSUs of $3.0 million and $2.2 million for the three months ended March 30, 2019 and March 31, 2018, respectively, and $8.3 million and $5.8 million for the nine months ended March 30, 2019 and March 31, 2018, respectively. 
The weighted-average fair value of RSUs and other awards granted was $51.01 and $54.81 per share for the three months ended March 30, 2019 and March 31, 2018, respectively, and $54.04 and $44.49 per share for the nine months ended March 30, 2019 and March 31, 2018, respectively. 
There were no changes to goodwill for the nine months ended March 30, 2019.
There were no stock options granted in the three and nine months ended March 30, 2019 and March 31, 2018. 
The Company recorded interest expense of $9.3 million and $12.4 million during the three months ended March 30, 2019, and March 31, 2018, respectively. The Company recorded interest expense of $33.9 million and $37.6 million during the nine months ended March 30, 2019 and March 31, 2018, respectively. 
No indicators or instances of impairment were identified in the nine months and fiscal year ended March 30, 2019 and June 30, 2018, respectively.
The weighted-average fair value of MSUs granted was $75.48 and $51.03 per share for the nine months ended March 30, 2019 and March 31, 2018, respectively. 
For the three months ended March 30, 2019 and March 31, 2018, and the nine months ended March 30, 2019 and March 31, 2018, no stock awards were determined to be anti-dilutive. Therefore, none were excluded from the calculation of diluted earnings per share. 
On January 26, 2018, the Company acquired a privately-held corporation specializing in the development of high-performance USB and video extension technology. Total cash consideration paid in connection with this acquisition was $57.8 million, net of cash acquired. The Company also agreed to pay up to an additional $16.0 million if the acquired business achieves certain financial milestones for the annual period ended August 31, 2018 and annual period ending August 31, 2019. Out of the $16.0 million, $8.0 million was paid during the nine months ended March 30, 2019. The acquired assets included $26.0 million of developed technology and $10.5 million of other intangible assets. The Company also recorded $41.9 million of goodwill in connection with this acquisition. The goodwill is not deductible for tax purposes.
The Company’s effective tax rate for the nine months ended March 31, 2018 was higher than the statutory rate primarily due to a $236.9 million discrete provisional charge for the Transition Tax, a $13.7 million discrete charge to remeasure deferred taxes as of the enactment date of the Act, and $13.1 million of discrete interest accruals for unrecognized tax benefits, partially offset by earnings of foreign subsidiaries, generated primarily by the Company's international operations managed in Ireland, that were taxed at lower rates and $8.3 million of discrete excess tax benefits generated by the settlement of share-based awards.Our gross margin percentages were 62.8% and 65.4% for the three months ended March 30, 2019 and March 31, 2018, respectively. Our gross margin decreased by 2.6 percentage points, primarily due to higher inventory reserves. 
Our gross margin percentages were 65.1% and 65.4% for the nine months ended March 30, 2019 and March 31, 2018, respectively. Our gross margin decreased by 0.3 percentage points, primarily due to higher inventory reserves.
and handheld computing products. The decrease in revenues in these markets was partially driven by the 13-week second quarter of fiscal year 2019, compared to the 14-week second quarter of fiscal year 2018. In addition, there was a one-time incremental $22.0 million of revenue recognized as a result of the sell-in accounting revenue transition during the second quarter of fiscal 2018. 
Research and development expenses were $107.1 million and $114.4 million for the three months ended March 30, 2019 and March 31, 2018, respectively, which represented 19.7% and 17.6% of net revenues for each respective period. The $7.3 million decrease was due to lower salaries and related personnel expenses. 
Research and development expenses were $330.1 million and $338.9 million for the nine months ended March 30, 2019 and March 31, 2018, respectively, which represented 18.8% and 18.3% of net revenues for each respective period. The $8.8 million decrease was due to lower salaries and related personnel expenses.Not applicable.The information set forth above under Part I, Item 1, Note 11 “Commitments and Contingencies” to the Condensed Consolidated Financial Statements is incorporated herein by reference.